Comprehensive exploration of chondrogenic bone tumors to identify molecular signatures and targeted therapies (ChondroTuProfiling)

Comprehensive exploration of chondrogenic bone tumors to identify molecular signatures and targeted therapies (ChondroTuProfiling) - ChondroTuProfiling

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033899

Enrollment

100

Registered

2024-03-14

Start date

2023-10-05

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chondrogenic Bone Tumors

Interventions

Group 1: Patients with diagnosed chondrogenic bone tumor

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of a chondrogenic bone tumor

Exclusion criteria

Exclusion criteria: No permission/consent of the patients. No other specific exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Explorative molecular-biological characterization of centrally and peripherally located chondrogenic bone tumors as well as the extracellular matrix and the tumor microenvironment	—

Secondary

Measure	Time frame
Clinical, histopathological and radiological parameters	—

Countries

Germany

Contacts

Public ContactJulian Maier

Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Freiburg

julian.maier@uniklinik-freiburg.de+4976127061301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026